Published 3 days ago • loading... • Updated 3 days ago

Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus (XLV:NYSEARCA)

Summary by Seeking Alpha

U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B Merck...

1 Articles

All

Left

Center

Right

U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B Merck...

3 days ago·United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right1Center0Last Updated3 days agoBias Distribution

100% Right

100% Right

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in United States 3 days ago on Sunday, March 30, 2025.

Sources are mostly out of (0)